Full-fledged internationl marketing at APSEV held in Taiwan at the end of this month

Exosome Isolation Reagent Kit / ExoCAS-2™
Exosome Isolation Reagent Kit / ExoCAS-2™
Exosome Isolation Reagent Kit / ExoCAS-2™
Exosome Isolation Reagent Kit / ExoCAS-2™

Microgentas (CEO Sehyun Shin), a company specialized in exosome isolation, will present a paper and exhibit new products at the Asia Pacific Societies for Extracellular Vesicles (APSEV) conference held in Taiwan at the end of this month.

Microgentas is a company founded by Professor Sehyun Shin of Korea University’s Leading Nano-Biofluignostic Research Center(ERC) based on the core technology of precision medicine and liquid biopsy. Microgentas developed a fusion of liquid biopsy and exosome isolation technologies, as well as a high-performance miRNA isolation technology, opening the way for precision medicine based on liquid biopsy,

The Asia Pacific Association for Extracellular Vesicles(APSEV) is as academic conference for research and advancement of extracellular vesicles held in Taipei. APSEV holds an annual conference attended by researchers and scientists from the Asia Pacific region and around the world. At the conference, Microgentas will unveil miRQuick™ using technology for high-performance extraction of miRNAs inside exosomes following ExoCAS™.

ExoCAS-2™ is a reagent kit that can easily and quickly isolate exosomes. Its biggest advantage is that it can obtain high yield and high purity exosomes within 20 minutes. In addition, the new product miRQuick™ replaces the existing complex and cumbersome two-step extraction process with one-step, and can extract exosomal miRNA at least 2 to 10 times more than existing products from plasma, serum, cell culture media, urine, and saliva.

Sehyun Shin, CEO of Microgentas, said, “It is meaningful to disclose the technology for ExoCAS™ and miRQuick™, which purifies exosome and miRNA inside exosomes with high performance, at this conference. Furthermore, we aim to leap into an exosome specialized company capable of extracting large quantities of exosomes and providing high-capacity exosome extraction, thus contributing to global bio industry.

Meanwhile, starting with the APSEV conference, Microgentas plan to participate several upcoming conferences including the International Society for Extracellular Vesicles (ISEV) in May, SELECTBIO in June, American Association for Clinical Chemistry (AACC) in July. 

[미국,중국,영국,독일,스위스,인도,이탈리아,프랑스] 

 

언론홍보 보도자료 배포 서비스 '제보왕'-보도자료 배포전문 기업 제보왕에서는 기업, 기관의 언론홍보에 적합한 보도자료를 주요방송 신문 잡지에 배포하는 보도자료 배포 전문 언론홍보 서비스를 80~100만원 이내의 금액으로 1년간 무제한으로 제공합니다. 해외 언론과 포털에도 보도자료 배포 가능합니다.

저작권자 © 제보왕 무단전재 및 재배포 금지